<html>
<head>PUBMED IDs for ZMYM2</head>
<body bgcolor='#C5F0F2'><h1>ZMYM2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20554971/'>Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.</a> October 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21214407/'>Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.</a> May 27  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21527531/'>Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.</a> September 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22236811/'>Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: a case study.</a> April 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22875628/'>Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements.</a> December 16  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22875613/'>Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.</a> April 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23594707/'>B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : rare case and review of the literature.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23594704/'>Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23594693/'>Early events in lymphopoiesis: an update.</a> October 24  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23751892/'>A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.</a> August 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24716227/'>Identification of Zinc Finger, MYM-type 2 (ZMYM2) as a regulator of sorafenib resistance in hepatocellular carcinoma cell lines.</a> November 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26283374/'>Screen for multi-SUMO-binding proteins reveals a multi-SIM-binding mechanism for recruitment of the transcriptional regulator ZMYM2 to chromatin.</a> January 5  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27005999/'>Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.</a> April 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27245147/'>FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).</a> March 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27292646/'>RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell Reprogramming.</a> June 14  2016<br></body></html>
